Cell Sorting Market Updates

Cell Sorting Market size was valued at USD 283.32 Million in 2023 and is poised to grow from USD 303.15 Million in 2024 to USD 521.27 Million by 2032, growing at a CAGR of 7% during the forecast period (2025-2032).

Cell sorting market players should focus on collaborations and partnerships to share their expertise and fast-track the development of novel cell sorting products. Developing affordable reagents and equipment required for cell sortings will also offer good business scope for new entrants in the market. Investing in research will be a non-negotiable strategy for all cell sorting companies operating around the world.   'Becton, Dickinson and Company ', 'Beckman Coulter, Inc. ', 'Bio-Rad Laboratories, Inc. ', 'Sony  ', 'Miltenyi Biotec GmbH ', 'Thermo Fisher Scientific ', 'Merck KGaA ', 'Sysmex Partec GmbH ', 'On-Chip Biotechnologies Co., Ltd. ', 'Cytonome/St, LLC ', 'Union Biometrica, Inc. ', 'BioLegend ', 'Cytek Biosciences ', 'Microsaic Systems ', 'Sartorius AG ', 'Verity Software House ', 'STEMCELL Technologies ', 'Cytognos S.L.  ', 'NanoCellect Biomedical, Inc. ', 'Oxford Nanopore Technologies'

Integration with Microfluidics: Microfluidic cell sorting is projected to emerge in popularity in the long run. Growing demand for cell sorting of small samples is expected to help this cell sorting market trend create new opportunities for companies in the long run. This also improves the application of cell sorting in precision and personalized medicine as well.  

Robust spending on medical research in the North American region makes it a leader in the global cell sorting market. The presence of multiple pharmaceutical and biotechnology companies, growing investments in cell research, and availability of supportive government funding for research are aiding the dominance of this region. Canada and the United States are estimated to emerge as the leading markets for cell sorting providers operating in this region going forward. High adoption of personalized and precision medicine coupled with rising demand for regenerative medicine are also creating new business scope for cell sorting companies in the North American region.